SCHEMBL5456877

SCHEMBL5456877

Cc1cccnc1C(O)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
HTT P42858 1/20 0.42
ATM Q13315 1/20 0.42
LMNA P02545 3/20 0.42
MAPK1 P28482 2/20 0.42
L3MBTL1 Q9Y468 4/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN7 P35236 1/20 0.41
BLM P54132 1/20 0.41
ESR2 Q92731 1/20 0.41
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
FDPS P14324 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
PTPRA P18433 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7553930 0.84 NOS3 (0.46) NPC1RAB9AHTTATMLMNA
SCHEMBL3741239 0.83 SMN1; SMN2 (0.42) NPC1RAB9AHTTATMLMNA
SCHEMBL23886543 0.79 NAPRT (0.43) HTTLMNAMAPK1L3MBTL1KMT2A
SCHEMBL30370713 0.79 NAPRT (0.43) HTTLMNAMAPK1L3MBTL1KMT2A
SCHEMBL12238416 0.79 LMNA (0.41) NPC1LMNAMAPK1L3MBTL1KMT2A
SCHEMBL12238415 0.79 LMNA (0.41) NPC1LMNAMAPK1L3MBTL1KMT2A
SCHEMBL895915 0.79 SMN1; SMN2 (0.41) NPC1RAB9AHTTATMLMNA
SCHEMBL5457864 0.79 CYP1A2 (0.47) NPC1RAB9AHTTLMNAMAPK1
Hydrochloric Acid SCHEMBL30370512 0.78 NAPRT (0.42) HTTLMNAMAPK1L3MBTL1KMT2A
Hydrochloric Acid SCHEMBL23886539 0.78 NAPRT (0.42) HTTLMNAMAPK1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 NPC1 1089/4885RAB9A 1528/4885HTT 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.